Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-12-01 / Urol Oncol 2016 12;34(12):538-547Dendritic cell vaccines for melanoma: past, present and future
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-11-29 / Melanoma Manag 2016 Dec;3(4):273-289Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-23 / Exp. Hematol. 2017 Feb;46:48-55Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-14 / Bone Marrow Transplant. 2017 Feb;52(2):228-237Novel vaccines for glioblastoma: clinical update and perspective
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-11-01 / Immunotherapy 2016 11;8(11):1293-1308Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers
/in Esophageal Carcinoma, Hyperthermia, International Publications, Uterine Cancer /von 2016-11-01 / Cell Rep 2016 11;17(6):1621-1631Dendritic Cells and Cancer Immunity
/in Dendritic Cells, International Publications /von 2016-10-25 / Trends Immunol. 2016 12;37(12):855-865Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-10-18 / Oncoimmunology 2016;5(11):e1232237Immunotherapy in pancreatic cancer treatment: a new frontier
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-10-17 / Therap Adv Gastroenterol 2017 Jan;10(1):168-194
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de